Business Wire - August 19, 2004
Retractable is the sole U.S. syringe manufacturer to receive a contract under the President's Emergency Plan, which was launched by President Bush last year as a rapid intervention strategy to prevent seven million new HIV infections in fourteen AIDS ravaged countries in Africa and the Caribbean. Countries covered by the program were given the opportunity to evaluate and indicate the syringes they preferred from among all those available worldwide. International health organizations have long recognized that the reuse of syringes in these countries plays a significant part in the HIV pandemic. VanishPoint(R) automated retraction safety devices not only prevent reuse but also virtually eliminate accidental needlestick injuries and minimize hazardous medical waste, a major problem in developing countries.
The Honorable Charity Kaluki Ngilu, M.P., Kenya's Minister of Health, said: "Kenya recognizes the importance of good syringe technology and is delighted to finally bring VanishPoint state-of-the-art technology to Kenya under the President's Emergency Plan. The selection of these devices is important to Kenya because they prevent our nurses and other medical personnel from being exposed to dangerous contaminated needles." She added: "When I first saw the VanishPoint syringe demonstrated at the International Conference on AIDS in Nairobi last September, I knew this technology could become a key part of an effective AIDS prevention strategy. Immediate implementation of these devices through initial funding from the U.S. will have far-reaching effects in the fight against AIDS in Kenya."
"We are deeply gratified for the opportunity to help protect African patients and healthcare workers from potentially contaminated needles," said Thomas J. Shaw, President and CEO. "We commend the U.S. administration and Congress for implementing this landmark program, and we are committed to working closely with African and Caribbean health ministries and U.S. agencies and their contractors to immediately supply these devices to help prevent transmission of HIV." Shaw went on to say that "this contract represents a milestone in the fulfillment of the original mission of our company, which was and is to halt the spread of HIV/AIDS and other bloodborne diseases in Africa by preventing syringe reuse and needlestick injuries. This is a war on AIDS, and our employees and shareholders are proud to be playing a part in it."
Retractable Technologies, Inc. manufactures and markets VanishPoint(R) automated retraction safety syringes and blood collection devices, which virtually eliminate health care worker exposure to accidental needlestick injuries. These revolutionary devices use a patented friction ring mechanism that causes the contaminated needle to retract automatically from the patient into the barrel of the device, a feature that is designed to prevent reuse. VanishPoint(R) safety needle devices are distributed by various specialty and general line distributors. For more information on Retractable, visit our Web site at www.vanishpoint.com.
Forward-looking statements in this press release are made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995 and reflect the Company's current views with respect to future events. The Company believes that the expectations reflected in such forward-looking statements are accurate. However, the Company cannot assure you that such expectations will materialize. The Company's actual future performance could differ materially from such statements. Factors that could cause or contribute to such differences include, but are not limited to: the impact of dramatic increases in demand; the Company's ability to quickly increase its production capacity in the event of a dramatic increase in demand; the Company's ability to access the market; the Company's ability to decrease production costs; the Company's ability to continue to finance research and development as well as operations and expansion of production; the increased interest of other syringe marketers in providing safety needle devices to their customers; and other risks and uncertainties that are detailed from time to time in the Company's periodic reports filed with the Securities and Exchange Commission.
CONTACT: Retractable Technologies, Inc., Little Elm
Investor Contact:
Douglas W. Cowan, 888-806-2626 or 972-294-1010
rtifinancial@vanishpoint.com
or
Media Contact:
Phillip L. Zweig, 212-490-0811 or 214-912-7415 (cell)
plzweig@aol.com
SOURCE: Retractable Technologies, Inc.
040819
BW040813
Copyright © 2004 - Business Wire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Business Wire, Permissions Desk, Business Wire, 1185 Avenue of the Americas, 3rd Floor, New York, NY 10036; Tel: (212) 575-8822; FAX: (212) 575-1854. http://www.businesswire.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2004. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2004. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .